{"product_id":"addiction-research-methods-isbn-9781405176637","title":"Addiction Research Methods","description":"Addiction Research Methods’ is a comprehensive handbook for health professionals, policy-makers and researchers working and training in the field of addiction.  \u003cp\u003eThe book provides a clear, comprehensive and practical guide to research design, methods and analysis within the context of the field of alcohol and other drugs. The reader is introduced to fundamental principles and key issues; and is orientated to available sources of information and key literature.\u003c\/p\u003e \u003cp\u003eWritten by a team of internationally acclaimed contributors, the book is divided into six major sections: Introduction; Research Design; Basic Toolbox; Biological Models; Specialist Methods; and Analytical Methods. Each chapter offers an introduction to the background and development of the discipline in question, its key features and applications, how it compares to other methods\/analyses and its advantages and limitations.\u003c\/p\u003e \u003cp\u003eFEATURES\u003c\/p\u003e \u003cul\u003e \u003cli\u003eList of useful websites and assistive technology.\u003c\/li\u003e \u003cli\u003eCase study examples\u003c\/li\u003e \u003cli\u003eList of useful hermeneutics\u003c\/li\u003e \u003cli\u003eRecommended reading list\u003c\/li\u003e \u003cli\u003eContains exercises to help the reader to develop their skills.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eList of contributors ix\u003c\/p\u003e \u003cp\u003eAcknowledgements xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Introduction 1\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePeter G. Miller, John Strang and Peter M. Miller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 1\u003c\/p\u003e \u003cp\u003e1.2 Where to start? 1\u003c\/p\u003e \u003cp\u003e1.3 Does theory matter? 2\u003c\/p\u003e \u003cp\u003e1.4 The literature review 3\u003c\/p\u003e \u003cp\u003e1.5 Which method suits my question – is a screwdriver better than a saw? 4\u003c\/p\u003e \u003cp\u003e1.6 Focus and structure of the book 5\u003c\/p\u003e \u003cp\u003e1.7 Terminology 6\u003c\/p\u003e \u003cp\u003e1.8 The need for a wider perspective and more careful selection of study design 8\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection I: Research Fundamentals\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Reliability and validity 11\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eGerhard Bühringer and Monika Sassen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 11\u003c\/p\u003e \u003cp\u003e2.2 Background: Reliability and validity in addiction research 11\u003c\/p\u003e \u003cp\u003e2.3 Reliability and validity in addiction research 16\u003c\/p\u003e \u003cp\u003e2.4 Strengthening the quality of your results and conclusions: A brief checklist to improve reliability and validity 19\u003c\/p\u003e \u003cp\u003e2.5 Summary 24\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Sampling strategies for addiction research 27\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eLisa Kakinami and Kenneth R. Conner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 27\u003c\/p\u003e \u003cp\u003e3.2 Probability sampling 27\u003c\/p\u003e \u003cp\u003e3.3 Non-probability sampling 32\u003c\/p\u003e \u003cp\u003e3.4 Qualitative sampling 36\u003c\/p\u003e \u003cp\u003e3.5 Selecting your sampling approach 37\u003c\/p\u003e \u003cp\u003e3.6 Technical considerations 37\u003c\/p\u003e \u003cp\u003e3.7 Conclusion 40\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Experimental design issues in addiction research 43\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRobert West\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 43\u003c\/p\u003e \u003cp\u003e4.2 What constitutes an experiment? 43\u003c\/p\u003e \u003cp\u003e4.3 Is an experiment appropriate? 44\u003c\/p\u003e \u003cp\u003e4.4 What kind of experimental design? 44\u003c\/p\u003e \u003cp\u003e4.5 What intervention and comparison conditions? 48\u003c\/p\u003e \u003cp\u003e4.6 What target population and recruitment strategy? 50\u003c\/p\u003e \u003cp\u003e4.7 What sample size? 52\u003c\/p\u003e \u003cp\u003e4.8 What outcome measures? 53\u003c\/p\u003e \u003cp\u003e4.9 What statistical analyses? 55\u003c\/p\u003e \u003cp\u003e4.10 Conclusions 56\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Qualitative methods and theory in addictions research 59\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eTim Rhodes and Ross Coomber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 59\u003c\/p\u003e \u003cp\u003e5.2 Theory 59\u003c\/p\u003e \u003cp\u003e5.3 A recurring debate 62\u003c\/p\u003e \u003cp\u003e5.4 Principles for practice 63\u003c\/p\u003e \u003cp\u003e5.5 Data generation 64\u003c\/p\u003e \u003cp\u003e5.6 Analysis 70\u003c\/p\u003e \u003cp\u003e5.7 Conclusions 73\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Ethical issues in alcohol, other drugs and addiction-related research 79\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePeter G. Miller, Adrian Carter and Wayne Hall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 79\u003c\/p\u003e \u003cp\u003e6.2 Key concepts 79\u003c\/p\u003e \u003cp\u003e6.3 Major ethical frameworks 80\u003c\/p\u003e \u003cp\u003e6.4 Addiction-specific ethical issues 83\u003c\/p\u003e \u003cp\u003e6.5 Writing an ethics application 87\u003c\/p\u003e \u003cp\u003e6.6 Ethical processes in different countries 87\u003c\/p\u003e \u003cp\u003e6.7 Influence of funding body 88\u003c\/p\u003e \u003cp\u003e6.8 Ethical dissemination 89\u003c\/p\u003e \u003cp\u003e6.9 Conclusion 89\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection II: Basic Toolbox\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Surveys and questionnaire design 97\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eLorraine T. Midanik and Krista Drescher-Burke\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 97\u003c\/p\u003e \u003cp\u003e7.2 Brief history 97\u003c\/p\u003e \u003cp\u003e7.3 Survey research designs 98\u003c\/p\u003e \u003cp\u003e7.4 Advantages and limitations of survey research designs 99\u003c\/p\u003e \u003cp\u003e7.5 Modes of data collection 100\u003c\/p\u003e \u003cp\u003e7.6 Questionnaire design 101\u003c\/p\u003e \u003cp\u003e7.7 Piloting the questionnaire 104\u003c\/p\u003e \u003cp\u003e7.8 Technological assistance 105\u003c\/p\u003e \u003cp\u003e7.9 Common challenges 106\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Interviews 109\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eBarbara S. McCrady, Benjamin Ladd, Leah Vermont and Julie Steele\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 109\u003c\/p\u003e \u003cp\u003e8.2 Why interviews? 109\u003c\/p\u003e \u003cp\u003e8.3 Reliability and validity of self-reported information 110\u003c\/p\u003e \u003cp\u003e8.4 Interviewing skills 112\u003c\/p\u003e \u003cp\u003e8.5 Types of interviews 116\u003c\/p\u003e \u003cp\u003e8.6 Types of interview data 118\u003c\/p\u003e \u003cp\u003e8.7 Technological resources 120\u003c\/p\u003e \u003cp\u003e8.8 Summary 120\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Scales for research in the addictions 127\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eShane Darke\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 127\u003c\/p\u003e \u003cp\u003e9.2 Screening instruments 128\u003c\/p\u003e \u003cp\u003e9.3 Frequency of substance use 130\u003c\/p\u003e \u003cp\u003e9.4 Multi-dimensional scales 133\u003c\/p\u003e \u003cp\u003e9.5 Dependence 135\u003c\/p\u003e \u003cp\u003e9.6 Psychopathology 139\u003c\/p\u003e \u003cp\u003e9.7 Summary 143\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Biomarkers of alcohol and other drug use 147\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eScott H. Stewart, Anton Goldmann, Tim Neumann and Claudia Spies\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 147\u003c\/p\u003e \u003cp\u003e10.2 Uses of state biomarkers in research 147\u003c\/p\u003e \u003cp\u003e10.3 General principles when considering biomarkers 149\u003c\/p\u003e \u003cp\u003e10.4 Summary 156\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Quantitative data analysis 163\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJim Lemon, Louisa Degenhardt, Tim Slade and Katherine Mills\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 163\u003c\/p\u003e \u003cp\u003e11.2 Imagining data – planning the study 163\u003c\/p\u003e \u003cp\u003e11.3 Collecting data – gathering the measurements 165\u003c\/p\u003e \u003cp\u003e11.4 Organising data – structuring the measurements 166\u003c\/p\u003e \u003cp\u003e11.5 Describing data – what do the data look like? 167\u003c\/p\u003e \u003cp\u003e11.6 Manipulating data 171\u003c\/p\u003e \u003cp\u003e11.7 Relationships within the data 173\u003c\/p\u003e \u003cp\u003e11.8 Interpreting relationships within the data 177\u003c\/p\u003e \u003cp\u003e11.9 Conclusion and exercises 178\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection III: Real World Research Methods\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Applied research methods 187\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDavid Best and Ed Day\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 187\u003c\/p\u003e \u003cp\u003e12.2 Auditing clinical activity in the city 189\u003c\/p\u003e \u003cp\u003e12.3 Needs assessment 190\u003c\/p\u003e \u003cp\u003e12.4 Qualitative research approaches 192\u003c\/p\u003e \u003cp\u003e12.5 Evaluation research 193\u003c\/p\u003e \u003cp\u003e12.6 The audit cycle 197\u003c\/p\u003e \u003cp\u003e12.7 Measuring outcomes in applied settings 197\u003c\/p\u003e \u003cp\u003e12.8 Overview and conclusions 198\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Conducting clinical research 201\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJalie A. Tucker and Cathy A. Simpson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Conducting clinical research 201\u003c\/p\u003e \u003cp\u003e13.2 Discussion and conclusions: The role of the practitioner-researcher 211\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IV: Biological Methods\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Psychopharmacology 223\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJason White and Nick Lintzeris\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 223\u003c\/p\u003e \u003cp\u003e14.2 Psychopharmacology: drugs, behaviour, physiology and the brain 223\u003c\/p\u003e \u003cp\u003e14.3 Measuring drug effects 226\u003c\/p\u003e \u003cp\u003e14.4 Human drug self-administration 229\u003c\/p\u003e \u003cp\u003e14.5 Drug withdrawal and craving 231\u003c\/p\u003e \u003cp\u003e14.6 Summary 232\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Imaging 235\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAlastair Reid and David Nutt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Introduction 235\u003c\/p\u003e \u003cp\u003e15.2 Introduction to neuroimaging 235\u003c\/p\u003e \u003cp\u003e15.3 Imaging techniques 235\u003c\/p\u003e \u003cp\u003e15.4 Image analysis 241\u003c\/p\u003e \u003cp\u003e15.5 Some considerations when setting up an imaging study 244\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Genes, genetics, genomics and epigenetics 249\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDavid Ball and Irene Guerrini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16.1 Introduction 249\u003c\/p\u003e \u003cp\u003e16.2 Animal studies 252\u003c\/p\u003e \u003cp\u003e16.3 Quantitative genetics 254\u003c\/p\u003e \u003cp\u003e16.4 Molecular genetics 256\u003c\/p\u003e \u003cp\u003e16.5 Why bother? 263\u003c\/p\u003e \u003cp\u003e16.6 An addiction gene 263\u003c\/p\u003e \u003cp\u003e16.7 Ethics 264\u003c\/p\u003e \u003cp\u003e16.8 Concluding remarks 264\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Animal models 269\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eLeigh V. Panlilio, Charles W. Schindler and Steven R. Goldberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17.1 Introduction 269\u003c\/p\u003e \u003cp\u003e17.2 Basic principles of behaviour: Reinforcement 269\u003c\/p\u003e \u003cp\u003e17.3 Basic principles of behaviour: Effects of environmental cues 270\u003c\/p\u003e \u003cp\u003e17.4 Drug self-administration: Simple schedules 270\u003c\/p\u003e \u003cp\u003e17.5 Drug self-administration: Using dose–effect curves to assess the effects of treatments 271\u003c\/p\u003e \u003cp\u003e17.6 Drug self-administration: Measuring the reinforcing effects of drugs 271\u003c\/p\u003e \u003cp\u003e17.7 Drug self-administration: Modelling the effects of environmental cues with second-order schedules 273\u003c\/p\u003e \u003cp\u003e17.8 Drug self-administration: Reinstatement 275\u003c\/p\u003e \u003cp\u003e17.9 Drug self-administration: Modelling the uncontrolled and compulsive nature of addiction 275\u003c\/p\u003e \u003cp\u003e17.10 Intracranial drug self-administration and intracranial electrical self-stimulation 276\u003c\/p\u003e \u003cp\u003e17.11 Drug self-administration: Advantages and disadvantages 278\u003c\/p\u003e \u003cp\u003e17.12 Conditioned place preference 278\u003c\/p\u003e \u003cp\u003e17.13 Drug discrimination 279\u003c\/p\u003e \u003cp\u003e17.14 Locomotor activity 279\u003c\/p\u003e \u003cp\u003e17.15 Adjunct procedures 281\u003c\/p\u003e \u003cp\u003e17.16 Integration of behavioural and neuroscience techniques 281\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection V: Specialist Methods\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Understanding contexts: Methods and analysis in ethnographic research on drugs 287\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJeremy Northcote and David Moore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18.1 Introduction 287\u003c\/p\u003e \u003cp\u003e18.2 Tracing the history of ethnographic drug research 288\u003c\/p\u003e \u003cp\u003e18.3 Designing ethnographic research 289\u003c\/p\u003e \u003cp\u003e18.4 Getting started 290\u003c\/p\u003e \u003cp\u003e18.5 Collecting data 292\u003c\/p\u003e \u003cp\u003e18.6 Analysing ethnographic data 293\u003c\/p\u003e \u003cp\u003e18.7 Producing ethnographic texts 294\u003c\/p\u003e \u003cp\u003e18.8 Conclusion 295\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Epidemiology 299\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMark Stoov´e and Paul Dietze\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19.1 Introduction 299\u003c\/p\u003e \u003cp\u003e19.2 Origins of epidemiology 299\u003c\/p\u003e \u003cp\u003e19.3 Definitions and uses of epidemiology in alcohol and other drug research 299\u003c\/p\u003e \u003cp\u003e19.4 Descriptive epidemiology 300\u003c\/p\u003e \u003cp\u003e19.5 Epidemiological research designs 301\u003c\/p\u003e \u003cp\u003e19.6 Analysis of case-control and cohort studies 308\u003c\/p\u003e \u003cp\u003e19.7 Experimental study designs 310\u003c\/p\u003e \u003cp\u003e19.8 Potential sources of error in epidemiology 311\u003c\/p\u003e \u003cp\u003e19.9 Summary 314\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Meta-analysis: Summarising findings on addiction intervention effects 319\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJohn W. Finney and Anne Moyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20.1 Introduction 319\u003c\/p\u003e \u003cp\u003e20.2 Overview of meta-analytic methods 319\u003c\/p\u003e \u003cp\u003e20.3 Issues in meta-analyses of addiction interventions 327\u003c\/p\u003e \u003cp\u003e20.4 Limitations 331\u003c\/p\u003e \u003cp\u003e20.5 Conclusion 331\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Drug trend monitoring 337\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePaul Griffiths and Jane Mounteney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21.1 Introduction 337\u003c\/p\u003e \u003cp\u003e21.2 Point of departure – divergent policy perspectives, difficulties in definition and temporal relevance 337\u003c\/p\u003e \u003cp\u003e21.3 International, national and local drug monitoring mechanisms 338\u003c\/p\u003e \u003cp\u003e21.4 Challenges in monitoring illicit drug use 339\u003c\/p\u003e \u003cp\u003e21.5 An overview of common information sources and some of their limitations 341\u003c\/p\u003e \u003cp\u003e21.6 Issues for the interpretation and analysis of data 345\u003c\/p\u003e \u003cp\u003e21.7 Mixed methods 347\u003c\/p\u003e \u003cp\u003e21.8 Triangulation 347\u003c\/p\u003e \u003cp\u003e21.9 Reliability and validity 348\u003c\/p\u003e \u003cp\u003e21.10 Reflections in a broken mirror: Pragmatic and imperfect solutions to an intractable problem 349\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Drug policy research 355\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJonathan P. Caulkins and Rosalie Liccardo Pacula\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22.1 Introduction 355\u003c\/p\u003e \u003cp\u003e22.2 Methods for quantitatively comparing an intervention’s benefits and costs 356\u003c\/p\u003e \u003cp\u003e22.3 Issues that arise in quantifying an intervention’s benefits and costs 360\u003c\/p\u003e \u003cp\u003e22.4 Methods for estimating an intervention’s effects 362\u003c\/p\u003e \u003cp\u003e22.5 Modelling methods 365\u003c\/p\u003e \u003cp\u003e22.6 Summary 366\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VI: Beyond Research\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Concluding remarks 375\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePeter G. Miller, John Strang and Peter M. Miller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23.1 Publishing addiction science 375\u003c\/p\u003e \u003cp\u003e23.2 Final thoughts 376\u003c\/p\u003e \u003cp\u003eIndex 377\u003c\/p\u003e  \u003cb\u003ePeter G Miller\u003c\/b\u003e is NHMRC Howard Florey Fellow in the School of Psychology at Deakin University, Australia. He is Commissioning Editor for the journal, \u003ci\u003eAddiction\u003c\/i\u003e.\u003cbr\u003e   \u003cp\u003e\u003cb\u003eJohn Strang\u003c\/b\u003e is Professor of the Addictions and Director of the National Addiction Centre, University of London. He is also Clinical Director of the addictions treatment services at the South London \u0026amp; Maudsley NHS Foundation Trust.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePeter M Miller\u003c\/b\u003e is Professor of the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina. He is Editor-in-Chief of the journal, \u003ci\u003eAddictive Behaviors\u003c\/i\u003e.\u003c\/p\u003e  Addiction Research Methods’ is a comprehensive handbook for health professionals, policy-makers and researchers working and training in the field of addiction.  \u003cp\u003eThe book provides a clear, comprehensive and practical guide to research design, methods and analysis within the context of the field of alcohol and other drugs. The reader is introduced to fundamental principles and key issues; and is orientated to available sources of information and key literature.\u003c\/p\u003e \u003cp\u003eWritten by a team of internationally acclaimed contributors, the book is divided into six major sections: Introduction; Research Design; Basic Toolbox; Biological Models; Specialist Methods; and Analytical Methods. Each chapter offers an introduction to the background and development of the discipline in question, its key features and applications, how it compares to other methods\/analyses and its advantages and limitations.\u003c\/p\u003e \u003cp\u003eFEATURES\u003c\/p\u003e \u003cul\u003e \u003cli\u003eList of useful websites and assistive technology.\u003c\/li\u003e \u003cli\u003eCase study examples\u003c\/li\u003e \u003cli\u003eList of useful hermeneutics\u003c\/li\u003e \u003cli\u003eRecommended reading list\u003c\/li\u003e \u003cli\u003eContains exercises to help the reader to develop their skills.\u003c\/li\u003e \u003c\/ul\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47988660404453,"sku":"NP9781405176637","price":113.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405176637.jpg?v=1761781158","url":"https:\/\/k12savings.com\/products\/addiction-research-methods-isbn-9781405176637","provider":"K12savings","version":"1.0","type":"link"}